According to The Insight Partners’ research, the global digital pathology market accounted for US$ 852.08 million in 2021 and is expected to hit US$ 1,892.40 million by 2028 to rise at an annual growth rate of 12.1% from 2021 to 2028. Technological advancement in digital pathology systems, growing preference of telepathology in remote areas, and digital pathology for cancer treatment are the critical factors aiding the market expansion.

The advent of information technology (IT) in healthcare has enabled physicians to maintain optimal workflow and meet the frequently changing patient’s preferences. Leica Biosystems introduced a software that can share digital pathology images and case data with experts outside the IT network. Computerization, robotic light microscopy, multiple fiber-optic communications, digital imagery, whole-slide imaging (WSI), LIS/LIMS interface, and high-speed networking are among the modern technologies assisting the pathologists.

People staying in remote regions need to travel to the urban areas for diagnosis, treatment, and follow-up. Digital pathology helps bridge the gap between patients from remote areas and diagnostic centers by providing an adequate access to healthcare organizations. A digital pathology setup is easy to install in rural labs and hospitals. It serves the remote telecommunication consultation, primarily for diagnosis and treatment. Several hospitals, primary care providers, private clinics, and other medical institutions offer remote telepathology services. Such systems reduce costs, benefit the organizations, and ensure patient’s satisfaction.

Periodic diagnosis is the first step of every cancer treatment. Traditional pathological methods can only detect tumors but find it gruesome to share the case for second review. This discrepancy is eliminated by digital pathology system that offers in-depth analysis and diagnosis of tumors. It involves the scanning of conventional glass slides and digitally unifying successive images into a single large image conveying the information. Pathologists, after hovering over the picture, gets an integrated and comprehensive overview of every unique cancer condition. Thus, the demand for technical advent in cancer treatment with the aspects discussed above bolsters the global digital pathology market.

On the other hand, the unreimbursed services hurdle the growth of the global digital pathology market.